Beaumont Financial Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-798
Closed -$229K – 394
2025
Q3
$229K Sell
798
-1
-0.1% -$268 0.02% 367
2025
Q2
$210K Buy
+799
New +$195K 0.02% 364
2022
Q2
– Sell
-893
Closed -$202K – 341
2022
Q1
$202K Buy
893
+6
+0.7% +$1.41K 0.02% 345
2021
Q4
$239K Hold
887
– – 0.02% 320
2021
Q3
$214K Hold
887
– – 0.02% 338
2021
Q2
$210K Buy
+887
New +$202K 0.02% 355

Other funds holding LH

Beaumont Financial Advisors's LH Position: Q4 2025 in Review

Beaumont Financial Advisors sold out of Labcorp (LH) in Q4 2025, closing a stake of 798 shares — an estimated $229K sold.

Beaumont Financial Advisors first reported a position in LH in Q2 2021 and held it in 6 quarters. The position peaked at $239K in Q4 2021. 1,029 funds tracked by Wall St. Rank hold LH as of Q4 2025.

  • Beaumont Financial Advisors reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
  • Beaumont Financial Advisors sold 798 Labcorp shares in Q4 2025, an estimated $229K.
  • Beaumont Financial Advisors first reported a position in Labcorp in Q2 2021 and held it in 6 quarters.
  • Beaumont Financial Advisors's Labcorp position peaked at $239K in Q4 2021.
  • 1,029 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Beaumont Financial Advisors's 13F filing for Q4 2025, filed 16 Jan 2026.